B-lymphoblastic leukemia/lymphoma with MYC and BCL2 gene rearrangements shows evidence for clonal evolution and mitotic recombination

J Hematop. 2023 Jun;16(2):111-117. doi: 10.1007/s12308-023-00541-y. Epub 2023 Apr 20.

Abstract

Background: B-lymphoblastic leukemia/lymphomas (B-ALL/LBL) are uncommon neoplasms that may be associated with a variety of cytogenetic and molecular changes. The mechanisms by which these changes arise have not been fully described.

Aims/purpose: This report describes an unusual case of B-ALL/LBL with complex clonal evolution that includes BCL2 and MYC gene rearrangements.

Methods: Immunophenotyping was performed by immunohistochemistry and flow cytometry. Traditional G-band karyotyping was accompanied by fluorescence in-situ hybridization (FISH) using break-apart and dual fusion probes. Single nucleotide polymorphisms were assessed using a high-density DNA microarray.

Results: The karyotype of the blasts showed reciprocal translocation of chromosomes 4 and 18, reciprocal translocation of chromosomes 8 and 14 with two copies of the oncogenic translocation derivative(14)t(8;14), and no normal chromosome 14. FISH studies showed complex IGH-BCL2 and IGH-MYC fusion signals.

Conclusions: A clonal evolution model involving multiple chromosomal translocations and mitotic recombination is postulated to account for the karyotype, FISH, and microarray results but leaves unresolved the exact order of the evolutionary changes.

Keywords: B-lymphoblastic leukemia/lymphoma; Clonal evolution; Mitotic recombination.

Publication types

  • Case Reports

MeSH terms

  • Clonal Evolution / genetics
  • Gene Rearrangement / genetics
  • Humans
  • Lymphoma*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma*
  • Proto-Oncogene Proteins c-bcl-2 / genetics

Substances

  • Proto-Oncogene Proteins c-bcl-2
  • BCL2 protein, human